Day: April 25, 2024

The nomination committee for the annual general meeting in December 2024 appointed The board member of SkiStar AB (publ) Vegard Søraunet has informed SkiStar’s nomination committee that he declines re-election at SkiStar’s annual general meeting, which is intended to be held in December 2024. This is due to a change of ownership in Nordic Ski & Mountains AB, which is a major shareholder in SkiStar. Søraunet, who represents Aeternum Capital, which continues to be a minority owner of Nordic Ski & Mountains AB, has been a member of SkiStar’s board since the annual general meeting in 2021. SkiStar’s nomination committee will work to propose a replacement in the regular nomination process before SkiStar’s annual general meeting in December. In accordance with the nomination committee’s instructions,...

Meriaura Group Plc Company announcement, Inside information                                                    25 April 2024 at 14.00 (CEST) SUPPLEMENT – Inside information: Meriaura Group’s board has conditionally decided to sell Meriaura’s minority ownership to Meriaura Invest to rearrange the group’s financing With this release, Meriaura Group Plc supplements the company announcement issued earlier today on April 25, 2024, at 8:30 (CEST). The supplement includes the legal forms of the companies mentioned in the first paragraph of the announcement, as well as the position within the group and the current estimate of the amount of minority ownership of Meriaura Ltd potentially to be sold in the arrangement under discussion. To rearrange the overall financing situation of the group, the Board of Directors of Meriaura...

MUNICH, Germany, April 25, 2024 (GLOBE NEWSWIRE) — Sono Group N.V. (the “Company”), a solar technology company, is pleased to announce a significant milestone in its corporate recovery. Following the successful conclusion of insolvency proceedings involving its subsidiary, Sono Motors GmbH, and the withdrawal of its own application for preliminary self-administration proceedings (reported in the Company’s Form 6-Ks filed on January 31, 2024 and February 29, 2024, respectively), the Company has received from the Financial Industry Regulatory Authority (FINRA) that the ‘Q’ will be removed from its ticker symbol, previously designated as SEVCQ, effective today. This change marks the end of the bankruptcy indication for Sono Group N.V., and the Company’s ordinary shares will be quoted on the over-the-counter market...

Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 11:30 am PST, 2:30 pm EST. Ted Karkus, CEO, will be hosting the presentation and answering questions at the conclusion. To access the live presentation, please use the following information: Planet MicroCap Showcase: VEGAS 2024Date: Wednesday, May 1, 2024 Time: 2:30pm Eastern Time (11:30am Pacific Time) Webcast: https://www.webcaster4.com/Webcast/Page/3026/50164 If you would like to book 1×1 investor meetings with ProPhase Labs, and to attend the Planet MicroCap Showcase: VEGAS 2024, please make sure you are registered here: https://planetmicrocapshowcase.com/signup 1×1 meetings...

The Foundation, a non-profit of the American Oncology Network, provides grants for essential non-medical expenses to cancer patients in need.American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients in Indiana and NevadaFrom left to right: Shelly Glenn, AON’s chief growth & relationship officer; Raja S. Mehdi, MD, medical oncologist at Hope Cancer Care of Nevada; Brian P. Mulherin, MD, medical oncologist at Hematology Oncology of Indiana; and Todd Schonherz, AON’s chief executive officer.FORT MYERS, Fla., April 25, 2024 (GLOBE NEWSWIRE) — American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing community oncology networks, today launched its American Oncology Cares Foundation through its partner practices Hematology Oncology of Indiana...

Harvia Plc press release 25 April 2024 at 3:00 p.m. EESTHarvia invites investors, analysts and media representatives to its Capital Markets Day on Wednesday, 29 May 2024 at 10:30 a.m. EEST. The Capital Markets Day will be held as a hybrid event. Institutional investors, analysts and media representatives are welcome to attend the event in Muurame, Teollisuustie 1–7, Finland. The Capital Markets Day can also be followed as a live webcast at https://harvia.videosync.fi/2024-05-29-cmd. A recording of the webcast and materials will be available after the event at www.harviagroup.com. CEO Matias Järnefelt and other members of Harvia’s Management Team will host the event. During the CMD, the Management Team will present Harvia’s strategy update and targets as well as other topical themes. Those participating in the event on site are requested...

LUBLIN, Poland, April 25, 2024 (GLOBE NEWSWIRE) — An inherent feature of oncology is personalization, i.e., conversion from the fit-to-all strategy based on applying the same chemotherapy regimens to all patients with a specific type of cancer to therapy individually tailored to the patient. Traditional methods such as immunohistochemistry and fluorescence in situ hybridization depend on subjective assessment of tissue samples, sometimes leading to imprecise results. This can result in either under-treatment or over-treatment, highlighting the need for better diagnostics. Recently, the concept of HER2-low expression has been proposed, indicating low expression of the HER2, undetectable by standard methods, but still being a positive predictive factor, and therefore justifying the use of targeted therapy.Fig. 1 Current paradigm...

STOUGHTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report first quarter 2024 financial results after the market closes on Thursday, May 9, 2024. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET. Conference Call Information To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q1 2024 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s...

SEATTLE and VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced it will report its first quarter 2024 financial results and provide an update on the cytisinicline development program on Thursday, May 9, 2024, at 4:30 PM EDT. To access the webcast, please use the following link: 1Q24 Earnings Webcast. Alternatively, you may access the live conference call by dialing 877-269-7756 (U.S. & Canada) or 201-689-7817 (International) and referencing conference ID 13744142. A webcast replay will be available approximately three hours after the call and will be archived on the website for 90 days. About Achieve...

LEXINGTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the first quarter of 2024 ended March 31, 2024 before the market opens on Tuesday, May 7, 2024. The Company will host a conference call and audio webcast that morning at 8:30 a.m. Eastern Time featuring remarks by Tracy Curley, CEO.Event:   iSpecimen First Quarter 2024 Results Conference CallDate:   Tuesday, May 7, 2024Time:   8:30 a.m. Eastern TimeDial in:   1-800-717-1738 (U.S. Toll Free) or 1-646-307-1865 (International)Webcast:   https://viavid.webcasts.com/starthere.jsp?ei=1666705&tp_key=0ac1c8e17f     For...